肝硬变患者外周血sIL-2R检测及其临床意义  

Soluble Interleukin-2 receptor (sIL-2R) in liver cirrhosis

作　　者：刘洪月[1] 何浩明[1] 苏彩女[1] 

机构地区：[1]江苏省连云港市第一人民医院消化科

出　　处：《蚌埠医学院学报》1999年第4期243-244,共2页Journal of Bengbu Medical College

摘　　要：目的：探讨肝硬变患者血清可溶性白细胞介素２受体（ｓＩＬ２Ｒ）水平及临床价值。方法：采用ＥＬＩＳＡ法测定３８例肝硬变患者（１２例经治疗后）和３５名正常人血清中ｓＩＬ２Ｒ含量。结果：肝硬变患者血清ｓＩＬ２Ｒ水平显著高于正常人组，经治疗后ｓＩＬ２Ｒ含量下降。结论：测定肝硬变患者血清中ｓＩＬ２Ｒ含量。Objective:To explore the change of serum sIL 2R levels in patients with liver cirrhosis and evaluate its potential value in clinical application.Methods:Serum sIL 2R level was detected in 38 patients(12 detected after treatment) and 35 healthy individuals by using sandwish ELISA assay.Results:Serum sIL 2R level in liver cirrhosis was significantly higher than that in normal control and lower in patients after treatment.Conclusions:It shows that the serum level of sIL 2R level is valuable in monitoring the cellular immunity condition in these patients .

关 键 词：肝硬化 SIL-2R 血清诊断 

分 类 号：R575.204[医药卫生—消化系统] R446.112[医药卫生—内科学]